In breast cancer independent studies have shown that similar to EVL, expression of miR-342 is associated with ERα(+) breast tumors http://www.oncomine.org[23,25-27] further supporting co-expression of miR-342 with EVL in ERα(+) tumors. Here, ESR1 is linked to breast cancer.